US Patent

US9168556 — Membrane nebulizer and method for welding a membrane to a carrier during the production of a membrane nebulizer

Formulation · Assigned to PARI Pharma GmbH · Expires 2032-09-01 · 6y remaining

Vulnerability score 42/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects a membrane nebulizer design that uses resistance welding to attach a membrane to a carrier.

USPTO Abstract

A membrane nebulizer for producing aerosol in an aerosol therapy device includes a membrane having several through-holes for nebulizing a fluid; and a laminar carrier having an opening, the membrane being arranged in the opening and fastened to the carrier in such a way that the nebulizing occurs on a first side of the carrier and the fluid is present at the membrane on the opposite second side of the carrier, wherein the membrane is welded to the carrier by means of a resistance welding method.

Drugs covered by this patent

Patent Metadata

Patent number
US9168556
Jurisdiction
US
Classification
Formulation
Expires
2032-09-01
Drug substance claim
No
Drug product claim
Yes
Assignee
PARI Pharma GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.